Cost-effectiveness analysis of ritonavir boosted nirmatrelvir for adult outpatients with mild to moderate COVID-19 in a European health system

Affiliations

• ¹ Internal Medicine Department, Hospital General Universitario de Elda, Spain; FISABIO Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain. Electronic address: Wikman_phi@gva.es.
• ² Documentation and Admission Department, Hospital Vega Baja, Orihuela (Alicante), Spain; FISABIO Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain.
• ³ Pharmacology Department, Hospital Vega Baja, Orihuela (Alicante), Spain; FISABIO Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain.
• ⁴ Internal Medicine Department, Hospital Clínico Universitario San Juan de Alicante, Spain; FISABIO Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain; Clinical Medicine Department, Miguel Hernández University, Elche (Alicante), Spain.
• ⁵ Internal Medicine Department, Hospital Vega Baja, Orihuela (Alicante), Spain; FISABIO Foundation for the Promotion of Health and Biomedical Research of Valencia Region, Valencia, Spain; Clinical Medicine Department, Miguel Hernández University, Elche (Alicante), Spain.